First test of drug OX118 in healthy people
Part of Immune system & allergy clinical trials.
This early-phase trial tests a new drug called OX118 in healthy volunteers to see if it is safe and how the body processes it. It is a first step in developing a potential new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You weigh between 50 and 100 kg (110-220 lbs) and have a healthy body weight.
- You are generally healthy with no serious medical conditions.
- You are not pregnant, breastfeeding, or planning pregnancy during the study.
- You do not smoke or use nicotine products.
- You agree to follow strict contraception rules if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral medication, VG290131, in healthy volunteers to see how the body processes it and if it is safe. It is an early-phase trial that requires participants to be in good health and follow specific rules about medications and lifestyle.
This study tests a new medicine called HL-1186 in healthy volunteers to see how safe it is and how the body handles it. If you join, you will help researchers gather early information that may lead to future treatments.
This is an early-stage study testing a new investigational drug called IG001119 in people who are in good health. Researchers will give increasing doses to small groups to learn how the drug is processed by the body and to check for any side effects.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This study tests a new medicine, ART105, in healthy adults to see if it is safe and how the body handles it. It is an early-stage trial, so it may not directly help you, but you would be contributing to medical research.
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
Hear when a new Immune System trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.